Dr. Agarwal’s Health Care Limited has reported a strong fiscal performance for FY26, achieving a total income of ₹2,125 crore, marking a 20.9% year-on-year growth. The company, which operates India’s largest eye care services chain, also saw its IndAS EBITDA climb to ₹614 crore and Profit After Tax surge by 52.4% to ₹168 crore. With 288 facilities now operational, the company continues its rapid expansion across India and international markets.
FY26 Financial Highlights
The company demonstrated strong operational and financial momentum throughout the fiscal year ending March 31, 2026. Key growth metrics highlight a robust 20.9% increase in total income to ₹2,125 crore, compared to the previous year. Profitability also improved significantly, with Profit After Tax (PAT) reaching ₹168 crore, representing a 52.4% year-on-year growth. Operating margins remained resilient, with IndAS EBITDA at ₹614 crore, reflecting a 22.2% year-on-year growth.
Operational Expansion and Clinical Excellence
Dr. Agarwal’s Health Care expanded its footprint aggressively, adding 57 facilities during the year, bringing the total network to 288 eye care facilities as of March 31, 2026. This growth is supported by a workforce of 968 doctors and 2,189 paramedics, serving over 3 million patients and performing more than 323,000 surgeries. The network now spans 14 states and 5 Union Territories in India, along with 19 facilities across 9 countries in Africa, maintaining a clear focus on its hub-and-spoke model to ensure scale and accessibility.
Strategic Growth Drivers
The company’s growth is underpinned by a diversified revenue mix, with surgeries contributing 66.7% of revenues, followed by opticals and consultations. Investments in technology, such as the AI-ready Neo Hospital Management System, have been central to improving operational efficiencies. With a 14.1% same-store sales growth (SSSG) for facilities set up through FY23 and emerging surgical facilities contributing 21.3% of revenues, the company has significant headroom for further growth. Plans are already underway to add 60 new facilities in the upcoming financial year, further solidifying its position in the eye care industry.
Source: BSE
